Characterisation of small molecule inhibitors of FGFR Key words: Fibroblast Growth Factor Receptor, Vascular Endothelial Growth Factor Receptor, cell signalling, novel molecular therapeutic, fragment based screening
نویسندگان
چکیده
Title Potent, selective inhibitors of FGFR define FGF dependence in pre-clinical cancer models. Authors and Affiliations M Squires, G Ward, G Saxty, V Berdini, A Cleasby, P King, P Angibaud, T Perera, L Fazal, D Ross, C Griffiths Jones, A Madin, R Benning, E Vickerstaffe, A O Brien, M Frederickson, M Reader, C Hamlett, M Batey, S Rich, M Carr, D Miller, R Feltell, A Thiru, S Bethell, L Devine, B Graham, A Pike, J Cosme, J Lewis, E Freyne, J Lyons, J Irving, C Murray, H Newell, N T Thompson.
منابع مشابه
Determination of Vascular Endothelial- and Fibroblast-Growth Factor Receptors in a Mouse Fibrosarcoma Tumor Model Following Photodynamic Therapy
The role of angiogenic molecules, like vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) in tumor angiogenesis was well confirmed. Photodynamic therapy (PDT) action is, to very high degree, based on tumor vasculature damage. Therefore, it seemed to be important to evaluate growth factor receptors after PDT. The extent of receptor expression was studied by immuno-histo...
متن کاملTherapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
Chemotherapy has become the global standard treatment for patients with metastatic or unresectable gastric cancer (GC), although outcomes remain unfavorable. Many molecular-targeted therapies inhibiting signaling pathways of various tyrosine kinase receptors have been developed, and monoclonal antibodies targeting human epidermal growth factor receptor 2 (HER2) have become standard therapy for ...
متن کاملAZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.
The fibroblast growth factor (FGF) signaling axis is increasingly implicated in tumorigenesis and chemoresistance. Several small-molecule FGF receptor (FGFR) kinase inhibitors are currently in clinical development; however, the predominant activity of the most advanced of these agents is against the kinase insert domain receptor (KDR), which compromises the FGFR selectivity. Here, we report the...
متن کاملTherapeutics, Targets, and Chemical Biology E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
Tumor angiogenesis is a degenerate process regulated by a complex network of proangiogenic factors. Existing antiangiogenic drugs used in clinic are characterized by selectivity for specific factors. Antiangiogenic properties might be improved in drugs that target multiple factors and thereby address the inherent mechanistic degeneracy in angiogenesis. Vascular endothelial growth factor (VEGF) ...
متن کاملE-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models.
Tumor angiogenesis is a degenerate process regulated by a complex network of proangiogenic factors. Existing antiangiogenic drugs used in clinic are characterized by selectivity for specific factors. Antiangiogenic properties might be improved in drugs that target multiple factors and thereby address the inherent mechanistic degeneracy in angiogenesis. Vascular endothelial growth factor (VEGF) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011